{"id":"https://openalex.org/W2695219720","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.2571","title":"TAX-TORC: A phase I trial of vistusertib (AZD2014) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies.","display_name":"TAX-TORC: A phase I trial of vistusertib (AZD2014) in combination with weekly paclitaxel with integrated pharmacodynamic (PD) and molecular characterization (MC) studies.","publication_year":2017,"publication_date":"2017-05-20","ids":{"openalex":"https://openalex.org/W2695219720","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.2571","mag":"2695219720"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.15_suppl.2571","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.2571","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.2571","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053619368","display_name":"Raghav Sundar","orcid":"https://orcid.org/0000-0001-9423-1368","observed_orcids":["https://orcid.org/0000-0001-9423-1368"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Raghav Sundar","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017721654","display_name":"Bristi Basu","orcid":"https://orcid.org/0000-0002-3562-2868","observed_orcids":["https://orcid.org/0000-0002-3562-2868"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Bristi Basu","raw_affiliation_strings":["University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom;","institution_ids":["https://openalex.org/I241749","https://openalex.org/I2802466933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050254542","display_name":"Richard H. Wilson","orcid":"https://orcid.org/0000-0001-8018-7730","observed_orcids":["https://orcid.org/0000-0001-8018-7730"]},"institutions":[{"id":"https://openalex.org/I126231945","display_name":"Queen's University Belfast","ror":"https://ror.org/00hswnk62","country_code":"GB","type":"education","lineage":["https://openalex.org/I126231945"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard H. Wilson","raw_affiliation_strings":["Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom;","institution_ids":["https://openalex.org/I126231945"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034748028","display_name":"James F. Spicer","orcid":"https://orcid.org/0000-0003-3732-8491","observed_orcids":["https://orcid.org/0000-0003-3732-8491","https://orcid.org/0009-0005-6890-2128"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James F. Spicer","raw_affiliation_strings":["King's College London, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London, London, United Kingdom;","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Hugh Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150388","display_name":"Velindre Cancer Centre","ror":"https://ror.org/049sr1d03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799279586","https://openalex.org/I4210150388"]},{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert Hugh Jones","raw_affiliation_strings":["Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom;","institution_ids":["https://openalex.org/I4210150388","https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080991347","display_name":"Matthew Krebs","orcid":"https://orcid.org/0000-0001-7540-3064","observed_orcids":["https://orcid.org/0000-0001-7540-3064"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew Krebs","raw_affiliation_strings":["The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Christie NHS Foundation Trust and The University of Manchester, Manchester, United Kingdom;","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109189418","display_name":"Michael Brada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Brada","raw_affiliation_strings":["University of Liverpool, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Liverpool, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024251435","display_name":"Denis Charles Talbot","orcid":"https://orcid.org/0000-0003-0431-3314","observed_orcids":["https://orcid.org/0000-0003-0431-3314"]},"institutions":[{"id":"https://openalex.org/I4210147381","display_name":"Oxford University Hospitals NHS Trust","ror":"https://ror.org/03h2bh287","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Denis Charles Talbot","raw_affiliation_strings":["Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;","institution_ids":["https://openalex.org/I4210147381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112929278","display_name":"Nicola L. Steele","orcid":"https://orcid.org/0000-0002-9405-4696","observed_orcids":["https://orcid.org/0000-0002-9405-4696"]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicola Steele","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;","institution_ids":["https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059792318","display_name":"Emma Hall","orcid":"https://orcid.org/0000-0001-5999-5020","observed_orcids":["https://orcid.org/0000-0001-5999-5020"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emma Hall","raw_affiliation_strings":["Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020610052","display_name":"Holly Tovey","orcid":"https://orcid.org/0000-0002-8324-0055","observed_orcids":["https://orcid.org/0000-0002-8324-0055"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Holly Tovey","raw_affiliation_strings":["Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085732690","display_name":"Suzanne Carreira","orcid":"https://orcid.org/0000-0002-5077-5379","observed_orcids":["https://orcid.org/0000-0002-5077-5379"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Suzanne Carreira","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045314558","display_name":"Fl\u00e1via Marcorin de Oliveira","orcid":"https://orcid.org/0000-0002-2939-4715","observed_orcids":["https://orcid.org/0000-0002-2939-4715"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Flavia M de Oliveira","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009096434","display_name":"Karen E. Swales","orcid":"https://orcid.org/0000-0002-6572-1293","observed_orcids":["https://orcid.org/0000-0002-6572-1293"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karen E Swales","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025206031","display_name":"Geetha Balarajah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Geetha Balarajah","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081319975","display_name":"Joanna Dawes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joanna C Dawes","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013217428","display_name":"Mona Parmar","orcid":"https://orcid.org/0000-0001-7818-4100","observed_orcids":["https://orcid.org/0000-0001-7818-4100"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mona Parmar","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Johann S. De Bono","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032401979","display_name":"Udai Banerji","orcid":"https://orcid.org/0000-0003-1503-3123","observed_orcids":["https://orcid.org/0000-0003-1503-3123"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Udai Banerji","raw_affiliation_strings":["The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"15_suppl","first_page":"2571","last_page":"2571"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.03680000081658363,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vistusertib","display_name":"vistusertib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/azd2014","display_name":"AZD2014","score":0.9950000047683716},{"id":"https://openalex.org/keywords/mtorc1-2-inhibition","display_name":"mTORC1/2 inhibition","score":0.8199999928474426},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9139999747276306},{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/s6k-phosphorylation","display_name":"S6K phosphorylation","score":0.6570000052452087},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/platelet-rich-plasma","display_name":"platelet-rich plasma","score":0.6520000100135803},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.7390000224113464},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4009999930858612},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4490000009536743},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.6119999885559082},{"id":"https://openalex.org/keywords/ca-125-response","display_name":"CA-125 response","score":0.6650000214576721},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6309999823570251},{"id":"https://openalex.org/keywords/molecular-characterization","display_name":"molecular characterization","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8715121150016785},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.5930830240249634},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.5466270446777344},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.536255955696106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5266155004501343},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5122801661491394},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5044292211532593},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.49968743324279785},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4553731679916382},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.426797479391098},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4059194326400757},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.39561134576797485},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.354159951210022},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3426215946674347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33284151554107666},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2941458821296692}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.15_suppl.2571","doi":"https://doi.org/10.1200/jco.2017.35.15_suppl.2571","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.15_suppl.2571","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2888480300","https://openalex.org/W4327578003","https://openalex.org/W4281729216","https://openalex.org/W2775545562","https://openalex.org/W2977497914","https://openalex.org/W2889866656","https://openalex.org/W2586935260","https://openalex.org/W1909876617","https://openalex.org/W2266712580","https://openalex.org/W2601980656"],"abstract_inverted_index":{"2571":[0],"Background:":[1],"In":[2,47,221],"ovarian":[3,43],"cells":[4],"isolated":[5],"from":[6],"ascites,":[7],"p-S6K":[8,22],"levels":[9,169,180],"were":[10,106,114,129,258],"found":[11],"to":[12,16,32,135,166,176],"correlate":[13],"with":[14,24,40,61,172,243,265,286,323,331],"resistance":[15],"chemotherapy.":[17],"We":[18,315],"hypothesised":[19],"that":[20],"inhibiting":[21],"signalling":[23],"dual":[25],"m-TORC1/2":[26],"inhibitor":[27],"vistusertib":[28,328],"(V)":[29],"in":[30,59,95,103,111,126,145,292,303,329,339],"addition":[31,163],"paclitaxel":[33,322],"(P)":[34],"would":[35],"improve":[36],"outcomes":[37],"of":[38,64,124,151,164,178,226,233,246,250,270,280,309,321,327],"patients":[39,227,330],"high-grade":[41],"serous":[42],"cancer":[44],"(HGSOC).":[45],"Methods:":[46],"the":[48,127,189,222,287],"dose":[49,206],"escalation":[50],"part,":[51],"weekly":[52],"P":[53,155,194,210],"80mg/m2IV":[54],"(6/7":[55],"weeks)":[56],"was":[57,89,185,207,274],"evaluated":[58,338],"combination":[60,320,334],"two":[62],"schedules":[63],"V;":[65],"Schedule":[66,79,104,112],"A:":[67],"V":[68,81,125,165,173,214],"(25,":[69],"50":[70],"or":[71,83],"75mg)":[72],"BID":[73,85,216],"PO":[74,86],"on":[75,197,276],"day(D)":[76],"1-3/week":[77],"and":[78,108,110,117,122,132,200,213,237,253,261,297],"B:":[80],"(75":[82],"100mg)":[84],"D1-2/week.":[87],"This":[88,184,333],"followed":[90],"by":[91],"an":[92,324],"expansion":[93,283],"cohort":[94,284],"25":[96],"HGSOC":[97,223,282],"patients.":[98],"Results:":[99],"Dose":[100],"limiting":[101],"toxicities":[102],"A":[105],"fatigue":[107],"mucositis":[109],"B":[113],"diarrhoea,":[115],"rash":[116],"fatigue.":[118],"The":[119],"AUC,":[120],"Cmax":[121],"half-life":[123],"50mg-cohort":[128,143],"2821ng.hr/ml,":[130],"926ng/ml":[131],"3hrs,":[133],"comparable":[134],"single":[136],"agent":[137],"studies.":[138],"PD":[139,201],"analysis":[140],"(from":[141],"six":[142],"patients)":[144],"platelet-rich":[146],"plasma":[147],"showed":[148],"increased":[149],"phosphorylation":[150,168],"Ser473":[152],"AKT":[153],"following":[154,193],"induction":[156],"(1.4":[157],"fold,":[158],"p":[159],"=":[160,182,306],"0.1378).":[161],"Following":[162],"P,":[167],"4hrs":[170],"post-treatment":[171],"fell":[174],"significantly":[175],"53%":[177],"pre-dose":[179],"(p":[181],"0.0495).":[183],"61%":[186],"lower":[187],"than":[188],"corresponding":[190],"time":[191],"point":[192],"alone.":[195],"Based":[196],"toxicity,":[198],"pharmacokinetic":[199],"evaluation,":[202],"recommended":[203],"phase":[204],"2":[205],"established":[208],"as":[209],"80mg/m2":[211],"D1":[212],"50mg":[215],"D1-3":[217],"for":[218,344],"6/7":[219],"weeks.":[220],"expansion,":[224],"96%":[225],"had":[228,239,311],"relapsed":[229],"within":[230],"12":[231],"months":[232],"last":[234],"platinum":[235],"therapy":[236],"100%":[238],"received":[240],"previous":[241,248],"paclitaxel,":[242],"a":[244,312,317,340],"median":[245,266],"3":[247,308],"lines":[249],"treatments.":[251],"RECIST":[252],"GCIG":[254],"CA125":[255],"response":[256],"rates":[257],"13/25":[259],"(52%)":[260],"15/25":[262],"(60%)":[263],"respectively,":[264],"progression":[267],"free":[268],"survival":[269],"5.5":[271],"months.":[272],"MC":[273],"performed":[275],"archival":[277],"tumor":[278],"tissue":[279],"24/25":[281],"patients,":[285],"most":[288],"common":[289],"mutations":[290,301],"occurring":[291],"p53":[293],"(100%),":[294],"BRCA":[295],"(17%),":[296],"MUC16":[298],"(17%).":[299],"ATM":[300],"occurred":[302],"17%":[304],"(n":[305],"4),":[307],"whom":[310],"response.":[313],"Conclusions:":[314],"report":[316],"highly":[318],"active":[319],"intermittent":[325],"schedule":[326],"HGSOC.":[332],"is":[335],"now":[336],"being":[337],"randomised":[341],"controlled":[342],"trial":[343,348],"this":[345],"indication.":[346],"Clinical":[347],"information:":[349],"NCT02193633.":[350]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-06-30T00:00:00"}